Oral Contraceptive Pills : Uses , Fuctions, Toxic Syndrommes..........

Oral cotraceptive pills are tablets that prevents conception. Perhaps its the most accepted contraceptive method in developing countries. Its principle function is to prevent conception and it doesn't give any protection against HIV and other STD's.

Oral Contraceptive Pills (OCP) are mainly two types.

1. Combiled OCP.

2. Progesteron OR Estrogen only Pills.

The mechanism of action of OCP is very simple. We know that female Menstrual cycle is devided into three phases.

1. Proliferative phase : Here estrogen is secreted by Ovary , which causes uterine endrometrial growth. After this phase there is sudden withdrwal af estrogen which causes Ovulation ( It is the fall of mature ovum into Peritoneal Cavity , which ultimately comes into the uterine tube and finally in uterus ).

2. Secretory phase : Here both Progesterone and Estrogen Causes more and more growth if endometrium and increase secretion by the uterine glands.

3. The Menstrual phase : Here sudden Withdrawal of Progesterone cause increase uterine contraction and shedding out of uterine endometrium with mature Ovum , which is visible as bleeding.

Now, OCP maintains a steady concentration of estrogen and progesterone into the body. Though , Ovulation occur due to sudden withdrawal of estrogen and OCP maintains estrogen level , so , there is no ovulation in the body. And , there is menstruation due to sudden withdrawal of progesterone , because , OCP intake should be stopped after 21 days. After this , the women will take 7 Iron tablets , and by this period there is sudden withdrwal of progesterone in the body. So , there is menstruation but without any ovulation.

Now, though there is no ovulation so , so Sperms inters into the vagina and uterus they can not find any mature ovum in female genital tract. So , there is no fertilization in the body. So, that women will not conceve .

By this way OCP maintains Contraception into the body.

Comments

Monoclonal Antibody Targets, Kills Leukemia Cells

Monoclonal Antibody Targets, Kills Leukemia Cells Researchers at the University of California, San Diego Moores Cancer Center have identified a humanized monoclonal antibody that targets and directly kills chronic lymphocytic leukemia (CLL) cells The findings, published in the online Early Edition of the Proceedings of the National Academy of Sciences on March 25, 2013 represent a potential new therapy for treating at least some patients with CLL, the most common type of blood cancer in the United States. CLL cells express high levels of a cell-surface glycoprotein receptor called CD44. Principal investigator Thomas Kipps, MD, PhD, Evelyn and Edwin Tasch Chair in Cancer Research, and colleagues identified a monoclonal antibody called RG7356 that specifically targeted CD44 and was directly toxic to cancer cells, but had little effect on normal B cells. Moreover, they found RG7356 induced CLL cells that expressed the protein ZAP-70 to undergo apoptosis or programmed cell dea...

CellSight Contributes Light-Sensitive Retinal Organoids and RPE Cells to New AMD Study

Department of Ophthalmology Written by Kara Mason | December 06, 2023 A partnership between ophthalmology researchers at the University of Colorado School of Medicine and Johns Hopkins University expands the understanding of how oxidative stress contributes to the development of choroidal neovascularization (CNV) in patients with age-related macular degeneration (AMD). To study the roles oxidative stress, a condition in which the body lacks antioxidants, and hypoxia play in the progression of AMD, Johns Hopkins University researchers turned to CellSight , the ocular stem cell and regeneration research program in the CU Department of Ophthalmology, for tools that allow researchers to explore specific conditions relevant to AMD. Using human-induced pluripotent stem cells, a type of stem cells that are generated or induced-from cells obtained from an adult person's skin or blood, CellSight investigators can recreate human retinal...

Baldness as a Signal of Heart Disease Risk

Baldness as a Signal of Heart Disease Risk Courtesy : NY Times and BMJ online. Baldness may indicate an increased risk for coronary heart disease. The risk is associated only with male pattern baldness, the kind that starts at the top or back of the head, and not with a receding hairline, according to researchers who reviewed six studies that included 37,000 participants. The analysis, published online in BMJ Open , found that baldness increased the risk for heart disease by between 30 and 40 percent compared with men with a full head of hair. They found the association among men 55 to 60 as well as among older men, and the more severe the baldness, the greater the risk. The reason for the association is unclear, but the authors suggest that known risk factors for heart disease — hypertension, high cholesterol, smoking and others — may affect both conditions, and that baldness may be a marker of atherosclerosis. In previous studies, baldness has been linked to an increased risk...

MEDICAL RESEARCH BANGLADESH ( BD )

Search This Blog